The poster will feature Rakuten Medical's ongoing global Phase 3 clinical trial evaluating ASP-1929 photoimmunotherapy in combination with pembrolizumab (anti-PD-1) as a first-line therapy for ...

Bicycle Therapeutics is a clinical-stage pharmaceutical company developing a novel class of medicines, referred to as Bicycle® molecules, for diseases that are underserved by existing ...

The STAR-101 trial is a first-in-human, multicenter, open-label, Phase 1 dose-escalation study designed to evaluate the safety, feasibility, and preliminary efficacy of SynKIR-110 in patients with ...

An oral presentation will feature ALLO-316 ... In addition, a Trial-in-Progress (TIP) poster will highlight the innovative design of the ongoing pivotal Phase 2 ALPHA3 trial evaluating cemacabtagene ...

Title: A phase 1 study to evaluate the safety and tolerability of the antibody-drug conjugate (ADC) MesoC2 (PF-08052666) in patients with advanced solid tumors MesoC2 (HBM9033/PF-08052666) is an ADC ...

Can you remember the first poster you owned, that you put up in your childhood or teenage bedroom? Was it a photographic image of a celebrity or sports hero? For centuries, posters have been used to ...

"We are honored that our Trial in Progress poster has been accepted for presentation at ASCO 2025," said Anastasios Maniakas, MD, PhD, Assistant Professor in the Department of Head and Neck Surgery ...

today provided additional details on the Trials in Progress poster presentation at the upcoming 2025 American Society for Clinical Oncology (ASCO) Annual Meeting, being held from May 30?

• In patients with persistent, recurrent, or metastatic HPV16-positive cervical cancer, VB10.16 combined with atezolizumab induced durable clinical responses. • The VB C-02 trial demonstrated that ...